Dysregulation of the RB1/E2F pathway, in which the retinoblastoma protein (RB1) normally represses E2F transcription factors to inhibit proliferation, can lead to EZH2 overexpression in SCLC (64). The gene discussed is RB1; the disease is small cell lung carcinoma.